Bli medlem
Bli medlem

Du är här


Episurf Medical AB: Redeye: Episurf Medical - With Focus Long-term

Redeye raises its valuation on Episurf Medical but lowers near term
estimates due to the corona crisis, which has halted elective
surgeries. Our medium to long term conviction is enhanced, however,
as we find the company's extensive clinical pipeline promising and
its substantial recent capital injection very reassuring.

Read more and download the research update:

Start following companies at Redeye to receive the latest equity
research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment


Författare Cision News

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.